Practical Guidelines for Managing Patients With Hidradenitis Suppurativa: An Update

J Cutan Med Surg. 2022 Sep-Oct;26(2_suppl):2S-24S. doi: 10.1177/12034754221116115. Epub 2022 Aug 24.

Abstract

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease that is characterized by the formation of comedones, papules, nodules, abscesses and sinus tracts in the axillary, inframammary, groin, and gluteal areas. Up to 3.8% of the Canadian population has HS, though due to a lack of awareness of HS, many patients are initially misdiagnosed and do not receive adequate treatment early on in the disease course. Once a diagnosis of HS is made, developing an effective management plan can be a dilemma for many providers. There is significant variability in response to any given therapy within the HS patient population and many HS patients have other medical comorbidities which must be taken into consideration. The aim of this review is to provide a practical approach for all healthcare providers to diagnose and manage HS and its associated comorbidities. A sample electronic medical record template for HS management was developed by the Canadian Hidradenitis Suppurativa Foundation Executive Board and is intended for use in clinical settings. This will help to increase collaboration between primary healthcare providers, dermatologists, and other medical specialists and ultimately improve the quality of care that HS patients receive.

Keywords: guidelines; hidradenitis suppurativa; review.

Publication types

  • Review

MeSH terms

  • Canada / epidemiology
  • Comorbidity
  • Hidradenitis Suppurativa* / diagnosis
  • Hidradenitis Suppurativa* / epidemiology
  • Hidradenitis Suppurativa* / therapy
  • Humans
  • Practice Guidelines as Topic*